130 related articles for article (PubMed ID: 15253616)
1. Which patients are prescribed COX-2 inhibitors rather than nonspecific anti-inflammatory drugs?
Paddon K; Green B
Aust Fam Physician; 2004 Jun; 33(6):475-6. PubMed ID: 15253616
[No Abstract] [Full Text] [Related]
2. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
Fenn GC; Grobler M; Schaffer D
Intern Med J; 2004 Nov; 34(11):647-9; discussion 650. PubMed ID: 15546461
[No Abstract] [Full Text] [Related]
3. [Antibiotic therapy in general medicine in Monastir, Tunisia].
Belghith Z; Khayeche F; Soltani MS; Ben Salem K; Bchir A
East Mediterr Health J; 1999 Mar; 5(2):328-32. PubMed ID: 10793809
[TBL] [Abstract][Full Text] [Related]
4. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
[TBL] [Abstract][Full Text] [Related]
5. [Selective COX-2 inhibitors--attitudes and prescription habits among general practitioners].
Eriksen SA; Nilsen JS; Spigset O; Slørdal L
Tidsskr Nor Laegeforen; 2003 May; 123(10):1334-7. PubMed ID: 12806671
[No Abstract] [Full Text] [Related]
6. Utilization patterns of cyclooxygenase-2 inhibitors among patients with arthritis in a managed care setting.
Foley KA; Barlas S; Hinnethal J; Watson DJ; Duong PT
Manag Care Interface; 2004 Jul; 17(7):21-6. PubMed ID: 15341245
[TBL] [Abstract][Full Text] [Related]
7. Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs.
Thiéfin G; Schwalm MS
Dig Liver Dis; 2011 Mar; 43(3):209-14. PubMed ID: 21051300
[TBL] [Abstract][Full Text] [Related]
8. Drug use trends for arthritis and other rheumatic conditions and effect of patient's age on treatment choice.
Desai RJ; Agarwal SJ; Aparasu RR
N C Med J; 2011; 72(6):432-8. PubMed ID: 22523849
[TBL] [Abstract][Full Text] [Related]
9. General practitioner prescribing patterns in Babol city, Islamic Republic of Iran.
Moghadamnia AA; Mirbolooki MR; Aghili MB
East Mediterr Health J; 2002; 8(4-5):550-5. PubMed ID: 15603037
[TBL] [Abstract][Full Text] [Related]
10. Prescribing for teenagers in New Zealand general practice.
Hall J; Martin I
N Z Med J; 2003 Nov; 116(1186):U685. PubMed ID: 14657968
[TBL] [Abstract][Full Text] [Related]
11. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.
Schneeweiss S; Glynn RJ; Avorn J; Solomon DH
J Clin Epidemiol; 2005 Jan; 58(1):98-102. PubMed ID: 15649677
[TBL] [Abstract][Full Text] [Related]
12. Co-prescriptions with itraconazole and fluconazole as a signal for possible risk of drug-drug interactions: a four-year analysis from Italian general practice.
Galatti L; Mazzaglia G; Greco A; Sessa E; Cricelli C; Schito GC; Nicoletti G; Spina E; Caputi AP
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):422-8. PubMed ID: 17323404
[TBL] [Abstract][Full Text] [Related]
13. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation.
Dai C; Stafford RS; Alexander GC
Arch Intern Med; 2005 Jan; 165(2):171-7. PubMed ID: 15668363
[TBL] [Abstract][Full Text] [Related]
14. From the editor-caution urged in prescribing psychotropic drugs for older patients.
Thomas SP
Issues Ment Health Nurs; 2005 May; 26(4):357-8. PubMed ID: 16020053
[No Abstract] [Full Text] [Related]
15. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.
Wettermark B; Hammar N; Fored CM; Leimanis A; Otterblad Olausson P; Bergman U; Persson I; Sundström A; Westerholm B; Rosén M
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):726-35. PubMed ID: 16897791
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of patients with skin and soft tissue infections. Results from the STRAMA survey of diagnoses and prescriptions among general practitioners].
André M; Eriksson M; Odenholt I
Lakartidningen; 2006 Oct 18-24; 103(42):3165-7. PubMed ID: 17111984
[No Abstract] [Full Text] [Related]
17. Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the tortoise and the hare revisited.
De Smet BD; Fendrick AM; Stevenson JG; Bernstein SJ
J Gen Intern Med; 2006 Jul; 21(7):694-7. PubMed ID: 16808768
[TBL] [Abstract][Full Text] [Related]
18. Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population.
Rahme E; Choquette D; Beaulieu M; Bessette L; Joseph L; Toubouti Y; LeLorier J
Am J Med; 2005 Nov; 118(11):1262-70. PubMed ID: 16271911
[TBL] [Abstract][Full Text] [Related]
19. Changes in HT prescriptions in Australia since 1992.
Coombs NJ; Boyages J
Aust Fam Physician; 2005 Aug; 34(8):697-8. PubMed ID: 16113712
[No Abstract] [Full Text] [Related]
20. Audit of prescribing practices of topical corticosteroids in outpatient dermatology clinics in north Palestine.
Sweileh WM
East Mediterr Health J; 2006; 12(1-2):161-9. PubMed ID: 17037234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
